Literature DB >> 25708457

Psychiatrists' self-stigma, the DGPPN guideline for psychosocial interventions, and contemporary treatment strategies.

Daniela Reich-Erkelenz1, Andrea Schmitt, Peter Falkai.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25708457     DOI： 10.1007/s00406-015-0586-0

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  9 in total

1.  Preventing compulsory admission to psychiatric inpatient care using psycho-education and monitoring: feasibility and outcomes after 12 months.

Authors:  Barbara Lay; Christina Blank; Silke Lengler; Thekla Drack; Marco Bleiker; Wulf Rössler
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-01       Impact factor: 5.270

2.  1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites.

Authors:  Raşit Tükel; Kubilay Aydın; Erhan Ertekin; Seda Şahin Özyıldırım; Mehmet Barburoğlu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-26       Impact factor: 5.270

3.  Stigmatization of psychiatrists and general practitioners: results of an international survey.

Authors:  Wolfgang Gaebel; Harald Zäske; Jürgen Zielasek; Helen-Rose Cleveland; Kathrin Samjeske; Heather Stuart; Julio Arboleda-Florez; Tsuyoshi Akiyama; Anja E Baumann; Oye Gureje; Miguel R Jorge; Marianne Kastrup; Yuriko Suzuki; Allan Tasman; Thiago M Fidalgo; Marek Jarema; Sarah B Johnson; Lola Kola; Dzmytry Krupchanka; Veronica Larach; Lyndy Matthews; Graham Mellsop; David M Ndetei; Tarek A Okasha; Ekaterina Padalko; Joyce A Spurgeoun; Magdalena Tyszkowska; Norman Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-05       Impact factor: 5.270

Review 4.  Assessment of potential cardiovascular risks of methylphenidate in comparison with sibutramine: do we need a SCOUT (trial)?

Authors:  Jochen Antel; Özgür Albayrak; Gerd Heusch; Tobias Banaschewski; Johannes Hebebrand
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-23       Impact factor: 5.270

5.  Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients.

Authors:  Jan Malte Bumb; Suna Su Aksay; Christoph Janke; Laura Kranaster; Olga Geisel; Peter Gass; Rainer Hellweg; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-18       Impact factor: 5.270

Review 6.  S3 guideline on psychosocial therapies in severe mental illness: evidence and recommendations.

Authors:  Uta Gühne; Stefan Weinmann; Katrin Arnold; Thomas Becker; Steffi G Riedel-Heller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-11       Impact factor: 5.270

7.  Pharmacotherapy of anxiety disorders in German-speaking countries: current status and changes between 1994 and 2011.

Authors:  Anna K Holl; Renate Grohmann; Martin Letmaier; Annamaria Painold; Sabrina Mörkl; Sermin Toto; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-08-20       Impact factor: 5.270

8.  Readiness to quit as a predictor for outcomes of smoking-reduction programme with transdermal nicotine patch or bupropion in a sample of 308 patients with schizophrenia.

Authors:  Kuan-Ju Chou; Hsing-Kang Chen; Chih-Hung Hung; Tzu-Ting Chen; Chun-Ming Chen; Bo-Jian Wu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-07-09       Impact factor: 5.270

Review 9.  Varenicline for smoking cessation in people with schizophrenia: systematic review and meta-analysis.

Authors:  Taro Kishi; Nakao Iwata
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-10-05       Impact factor: 5.270
  9 in total
  1 in total

1.  Predicting Medical Students' Current Attitudes Toward Psychiatry, Interest in Psychiatry, and Estimated Likelihood of Working in Psychiatry: A Cross-Sectional Study in Four European Countries.

Authors:  Ingeborg Warnke; Alex Gamma; Maria Buadze; Roman Schleifer; Carlos Canela; Bernd Strebel; Tamás Tényi; Wulf Rössler; Nicolas Rüsch; Michael Liebrenz
Journal:  Front Psychiatry       Date:  2018-03-12       Impact factor: 4.157
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.